@conference {41847,
	title = {Meat industry by-products : a cunningly disguised opportunity},
	booktitle = {Proceedings of the New Zealand Society of Animal Production},
	volume = {65},
	year = {2005},
	month = {Jan},
	pages = {340-343},
	publisher = {New Zealand Society of Animal Production},
	organization = {New Zealand Society of Animal Production},
	address = {Christchurch},
	abstract = {A pharmaceuticals division was first established in a New Zealand (NZ) meat company by Richmond Limited in mid 2001. This new division was a first in Australasia and had the stated objective of adding value to a range of relatively low-value by-products. At that time the supply of by-products throughout the meat industry in NZ was generally characterised by: {\textbullet} low prices; {\textbullet} low level of attention; {\textbullet} low levels of enthusiasm; {\textbullet} lack of market knowledge. This presentation will attempt to: {\textbullet} describe, in general terms, the establishment of a pharmaceuticals division as an integral part of a meat company; {\textbullet} describe the process of establishing relationships between suppliers and customers; {\textbullet} highlight areas of particular strengths and weakness in the pharmaceuticals arena for the NZ meat industry; {\textbullet} make some observations about the medium and longer term prognosis for the industry, in its widest sense. },
	issn = {1176-5283},
	author = {Rogerson A}
}
